Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005368579 | SCV006018144 | uncertain significance | Inborn genetic diseases | 2025-02-25 | criteria provided, single submitter | clinical testing | The c.4644G>T (p.L1548F) alteration is located in exon 31 (coding exon 31) of the KMT2C gene. This alteration results from a G to T substitution at nucleotide position 4644, causing the leucine (L) at amino acid position 1548 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |